BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3947650)

  • 1. The catalysis by heparin of the reaction between thrombin and antithrombin.
    Evington JR; Feldman PA; Luscombe M; Holbrook JJ
    Biochim Biophys Acta; 1986 Mar; 870(1):92-101. PubMed ID: 3947650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rate-determining step of the heparin-catalyzed antithrombin/thrombin reaction is independent of thrombin.
    Pletcher CH; Nelsestuen GL
    J Biol Chem; 1982 May; 257(10):5342-5. PubMed ID: 7068594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of factor IXa inhibition by antithrombin in the presence of unfractionated and low molecular weight heparins and fucoidan.
    Mauray S; de Raucourt E; Talbot JC; Dachary-Prigent J; Jozefowicz M; Fischer AM
    Biochim Biophys Acta; 1998 Sep; 1387(1-2):184-94. PubMed ID: 9748565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrostatic interactions in the heparin-enhanced reaction between human thrombin and antithrombin.
    Petersen LC; Jørgensen M
    Biochem J; 1983 Apr; 211(1):91-7. PubMed ID: 6870832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of antithrombin-thrombin complex formed in the presence and in the absence of heparin.
    Danielsson A; Björk I
    Biochem J; 1983 Aug; 213(2):345-53. PubMed ID: 6615439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement.
    Streusand VJ; Björk I; Gettins PG; Petitou M; Olson ST
    J Biol Chem; 1995 Apr; 270(16):9043-51. PubMed ID: 7721817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III.
    Danishefsky I; Ahrens M; Klein S
    Biochim Biophys Acta; 1977 Jun; 498(1):215-22. PubMed ID: 560216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceleration of the reaction between thrombin and antithrombin III by non-stoichiometric amounts of heparin.
    Björk I; Nordenman B
    Eur J Biochem; 1976 Sep; 68(2):507-11. PubMed ID: 976270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III.
    Griffith MJ
    J Biol Chem; 1982 Dec; 257(23):13899-302. PubMed ID: 7142182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III and heparin inactivation in thrombin involving reactions.
    Marciniak E
    Thromb Haemost; 1977 Aug; 38(2):486-93. PubMed ID: 579490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. Evidence for a mechanism involving competition with both antithrombin and thrombin for heparin binding.
    Peterson CB; Morgan WT; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7567-74. PubMed ID: 3584128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Most clot-bound thrombin activity is inhibited by plasma antithrombin during clot aging, but a very small fraction survives.
    Komatsu Y; Hayashi H
    Biol Pharm Bull; 2000 Apr; 23(4):502-5. PubMed ID: 10784436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-substrate reaction model for the heparin-catalyzed bovine antithrombin/protease reaction.
    Pletcher CH; Nelsestuen GL
    J Biol Chem; 1983 Jan; 258(2):1086-91. PubMed ID: 6822493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin conformation and the catalytic role of heparin. II. Is the heparin-induced conformational change in antithrombin required for rapid inactivation of thrombin?
    Peterson CB; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7559-66. PubMed ID: 3584127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.
    Björk I; Ylinenjärvi K; Olson ST; Hermentin P; Conradt HS; Zettlmeissl G
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):793-800. PubMed ID: 1417738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor.
    Björk I; Ylinenjärvi K; Olson ST; Bock PE
    J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A simple rate law that describes the kinetics of the heparin-catalyzed reaction between antithrombin III and thrombin.
    Nesheim ME
    J Biol Chem; 1983 Dec; 258(23):14708-17. PubMed ID: 6643505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin conformation and the catalytic role of heparin. I. Does cleavage by thrombin induce structural changes in the heparin-binding region of antithrombin?
    Peterson CB; Blackburn MN
    J Biol Chem; 1987 Jun; 262(16):7552-8. PubMed ID: 3584126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossed immunoelectrophoresis as applied to studies on complex formation. The binding of heparin to antithrombin III and the antithrombin III--thrombin complex.
    Andersson LO; Engman L; Henningsson E
    J Immunol Methods; 1977; 14(3-4):271-81. PubMed ID: 557071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of rabbit thrombomodulin on the inhibition of thrombin by the antithrombin-heparin complex: role of the acid domain of thrombomodulin].
    Bourin MC
    C R Acad Sci III; 1987; 304(8):173-6. PubMed ID: 3028582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.